Home / Intelligence / Case Studies / Early Payer Guidance Across Four Inflammatory Disease Areas
Trinity completed an early payer guidance engagement, conducting comprehensive secondary research across four inflammatory disease areas.
Geographic Scope: 
Client Situation
The client wanted to gain an in-depth understanding of four inflammatory disease areas to inform early stage decision-making.
Trinity’s Solution
Trinity conducted comprehensive secondary research in the following areas:
- Disease background including diagnosis, prognosis, epidemiology and unmet needs
- Current and future paradigm including lines of therapies and standard of care
- Pipeline analysis including key therapies in development and future treatment gamechangers
- Pricing and access landscape including pricing analysis, health technology assessment (HTA) outcomes and access status
Deliverables
Four disease-specific early payer guidance reports powered by comprehensive secondary research efforts into disease background, current and future treatment paradigm, pipeline analysis and pricing and access landscape.
Project Outcomes & Impact
Trinity’s comprehensive secondary research and landscape analyses helped the client to make early-stage decisions across therapeutic areas of interest from a future business development perspective.
Related Intelligence
Webinars
Looking Ahead to the November Election and Beyond
August 14, 2024 | 1:00 – 2:00 PM ET
As healthcare policy and the access landscape evolve, biopharma companies face challenges in navigating this ever-changing space. To help organizations prepare for and adapt to these changes, Trinity Life Sciences is offering a new webinar series, The Next Era in U.S. Healthcare Policy & Access. Join us for the first webinar in the series, Looking Ahead […]
Sign Up Now
Blog
Developing Effective Global Value Dossiers
Trinity Life Sciences recently worked with a large global pharma company to develop a new process for creating global value dossiers (GVDs) that better met the needs of regional affiliates. Matt O’Hara, who leads Trinity’s Evidence Strategy practice, shares insights into the project with Mary Fletcher-Louis, who recently joined Trinity to head Trinity’s Value Center […]
Read More
Blog
Rise with the Waves: UK – Now and Beyond – Four Policy Trends That May Shape Pharma’s Future
Executive Summary The global payer landscape is rapidly evolving and is expected to continuously impact manufacturers’ decisions about new launches, portfolio management, trial design and importantly, pricing and market access strategy. In the UK, several policy reforms have been introduced which are expected to improve patient access while balancing financial healthcare sustainability and overall market […]
Read More